MYH14 and autoimmune disease: In addition, nAbs against the SARS-CoV-2 S glycoprotein have been shown to cross-react with structurally similar human proteins such as α-myosin and transglutaminases, possibly leading to an increase in autoimmune diseases (Vojdani & Kharrazian, 2020).